| # | % | |||||
|---|---|---|---|---|---|---|
| 1601 | NEKTAR THERAPEUTICS COM | 2,094 | 23,000 | 0.00% | ||
| 1602 | DEXCOM INC | 259 | 22,000 | 0.00% | ||
| 1603 | MEDGENICS INC | 2,765 | 22,000 | 0.00% | ||
| 1604 | MIMEDX GROUP INC COM | 2,206 | 21,000 | 0.00% | ||
| 1605 | UNIQURE NV | 1,003 | 21,000 | 0.00% | ||
| 1606 | AUTOHOME INC | 604 | 20,000 | 0.00% | ||
| 1607 | IDERA PHARMACEUTICALS INCORPORATED COM NEW | 6,042 | 20,000 | 0.00% | ||
| 1608 | ATLANTIC COAST FINL CORP | 3,362 | 19,000 | 0.00% | ||
| 1609 | JINKOSOLAR HLDG CO LTD | 880 | 19,000 | 0.00% | ||
| 1610 | TREVENA INC | 1,831 | 19,000 | 0.00% | ||
| 1611 | CEMPRA INC | 658 | 18,000 | 0.00% | ||
| 1612 | NEUROCRINE BIOSCIE COM USD0.001 | 438 | 17,000 | 0.00% | ||
| 1613 | DEPHEID | 362 | 16,000 | 0.00% | ||
| 1614 | XENCOR INC COM | 1,234 | 15,000 | 0.00% | ||
| 1615 | Arrowhead Pharma Inc | 2,542 | 15,000 | 0.00% | ||
| 1616 | FLEXION THERAPEUTICS INC | 1,034 | 15,000 | 0.00% | ||
| 1617 | AMPHASTAR PHARMACEUTICALS IN COM | 1,182 | 14,000 | 0.00% | ||
| 1618 | LCNB CORP COM | 865 | 14,000 | 0.00% | ||
| 1619 | URBAN EDGE PPTYS COM | 637 | 14,000 | 0.00% | ||
| 1620 | AGENUS INC | 2,730 | 13,000 | 0.00% | ||
| 1621 | FLEETMATICS GROUP PLC | 265 | 13,000 | 0.00% | ||
| 1622 | ACADIA PHARMACEUTICALS INC COM | 379 | 13,000 | 0.00% | ||
| 1623 | TG THERAPEUTICS INC COM | 1,278 | 13,000 | 0.00% | ||
| 1624 | CLOVIS ONCOLOGY INC | 134 | 12,000 | 0.00% | ||
| 1625 | CELLDEX THERAPEUTICS INC NEW | 1,163 | 12,000 | 0.00% | ||
| 1626 | Curis, Inc | 5,813 | 12,000 | 0.00% | ||
| 1627 | ADAMAS PHARMACEUTICALS INC | 660 | 11,000 | 0.00% | ||
| 1628 | QORVO INC | 235 | 11,000 | 0.00% | ||
| 1629 | FOAMIX PHARMACEUTICALS LTD | 1,473 | 11,000 | 0.00% | ||
| 1630 | SELECT SECTOR SPDR TR | 148 | 9,000 | 0.00% | ||
| 1631 | SILVER WHEATON CORP | 698 | 8,000 | 0.00% | ||
| 1632 | EXACT SCIENCES CORP | 465 | 8,000 | 0.00% | ||
| 1633 | PACIRA PHARMACEUTICALS INC | 193 | 8,000 | 0.00% | ||
| 1634 | KERYX BIOPHARMACEUTICALS INCORPORATED | 2,083 | 7,000 | 0.00% | ||
| 1635 | RELYPSA INC | 347 | 6,000 | 0.00% | ||
| 1636 | Esperion Therapeutics Inc | 207 | 5,000 | 0.00% | ||
| 1637 | TETRAPHASE PHARMACEUTICALS INC COM | 537 | 4,000 | 0.00% | ||
| 1638 | SOLERA HOLDINGS INC | 30 | 2,000 | 0.00% | ||
| 1639 | STARZ SERIES A | 39 | 1,000 | 0.00% | ||
| 1640 | BAKER HUGHES INC | 20 | 1,000 | 0.00% | ||
| 1641 | S&P GLOBAL INC | 15 | 1,000 | 0.00% | ||
| 1642 | BRISTOL MYERS SQUIBB CO DBCV 9/1 | 1,000 | 1,000 | 0.00% | ||
| 1643 | COMMUNITY HEALTH SYS INC NEW | 60 | 0 | 0.00% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001040188-15-000041, filed 2015.11.06).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
